Head and Neck Squamous Cell Carcinomas Clinical Trials in Shenzhen, Nanshan

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)